Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange Detected- Page revision updated from v3.6.0 to v3.6.3, indicating a new build/version of the page rather than a change to the study content. This is a metadata-level update visible on the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew navigation/help sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study were added, improving access to participation and information. The Intervention/Treatment heading formatting was updated (from 'Intervention / Treatment' to 'Intervention/Treatment'), and the footer revision label now shows Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page shows a new revision label, updating from v3.5.4 to v3.5.5. This indicates a new version of the page with minor edits or fixes.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now displays Revision: v3.5.4 instead of v3.5.3, indicating a small release update to the page template.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page will now display an updated ClinicalTrials.gov release/version identifier (Revision v3.5.3 instead of v3.5.2). This reflects a technical site revision rather than a change to the underlying study details.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated to v3.5.2 and the previous v3.5.0 revision was removed.SummaryDifference0.0%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.